Actithera
MA - CambridgeBiotechnology
Focus: Actithera is a Cambridge-based biotechnology company specializing in radiotherapy innovations. The company operates at a focused, early-stage scale with limited public disclosure of size metrics.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
3-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Actithera?
AI assessmentConsider Actithera only if you have appetite for significant execution risk in exchange for early-stage equity upside in a potentially differentiated modality.
Why Work Here
- Early-stage radiotherapy specialist with potential to shape an emerging therapeutic category
- Active hiring in Clinical Operations and Regulatory Affairs suggests progression toward clinical validation
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Actithera
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.